1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Praxsyn Corporation

Praxsyn Corporation

PXYN
Praxsyn CorporationUS flagOther OTC
0.00
USD
- -
- -
6,347.00Market Cap
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
0.04
0.04
- -
0.05
0.25
0.11
Basic EPS, GAAP
- -
- -
- -
- -
-0.08
-0.13
-0.18
-0.02
- -
-0.05
0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
-0.07
-0.05
- -
-0.01
-0.09
-0.02
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
-0.01
-0.09
-0.19
-0.32
-0.21
-0.3
-0.19
-0.08
Tangible Book Value per Share
0.01
- -
- -
- -
- -
0.01
-0.1
-0.05
-0.03
0.01
0.01
Basic Weighted Avg Shares
6
6
28
10
10
32
43
71
134
269
585
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
1
2
- -
7
67
63
Operating Margin (%)
- -
- -
-742.85
-33.94
- -
-281.85
-267.78
- -
45.78
39.14
32.55
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
-1
-4
-8
-1
- -
-12
7
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
70.13
- -
43.42
Profit Margin (%)
- -
- -
-754.07
-33.94
- -
-300.77
-474.21
- -
3.29
-18.55
10.89
Working Capital
- -
- -
- -
- -
- -
- -
-1
-3
-6
-3
-17
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
-4
-3
-5
2
9
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
106.9
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
-3.92
- -
-26.89
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'15
Jun'15
Sep'15
ST Debt
4
3
3
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
593
625
634
Market Capitalization
14
11
10

Working Capital

FRC

•

in mil. unless spec.
Mar'15
Jun'15
Sep'15
Total Current Assets
15
14
13
Cash, Cash Equivalents & STI
2
5
1
Accounts Receivable, Net
12
7
11
Inventories
- -
1
1
Total Current Liabilities
16
20
29
Payables & Accruals
11
15
22
ST Debt
4
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-506.78%
-135.25%
Free Cash Flow
- -
2,391.98%
1,270.03%
Net Income, GAAP
- -
-1,036.55%
-5,470.05%
Sales/Revenue/Turnover
- -
- -
852.97%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
3
- -
- -
- -
7
2014
9
23
23
11
67
2015
14
18
20
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
-0.04
- -
- -
- -
-0.05
2015
- -
0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Sean Daly
Full Time Employees
66
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Address
61 Spectrum Las Vegas IL United States of America
IPO Date
Aug 16, 2010
CIK
0001346973
Website
praxsyn.com
Similar Companies
Al-Razi Medical Co. (9572.SR)
Godavari Drugs Limited (GODAVARI.BO)
Gennex Laboratories Limited (GENNEX.BO)
Irwin Naturals Inc. (IWINF)
Leafly Holdings, Inc. (LFLY)
Zynerba Pharmaceuticals, Inc. (0M40.L)
Business
Praxsyn Corporation (PXYN), a healthcare company, provides medical practitioners with non-narcotic, non-habit-forming medications and related services for pain management, erectile dysfunction, and metabolic therapies. The company formulates therapeutic and preventative agents in transdermal creams, patches, and oral capsules; offers custom compounded topical pain medications marketed to industrial health physicians and medical clinics; and provides revenue cycle management solutions through its Praxsyn Capital Corporation (PraxCapita) subsidiary for healthcare providers focusing on personal injury claims. Through subsidiaries including Praxsyn Medical Inc. and Mesa Pharmacy Inc., it engages in retail pharmacy, medical supplies, equipment distribution, medical billing, prescriber services, and optimized delivery of pain management pharmaceuticals. Praxsyn operates primarily in the United States, serving patients under the California workers' compensation system and preferred provider contracts; it targets healthcare providers, industrial health sectors, and patients requiring compliant medical claims processing. Founded in 2005 and headquartered in Scottsdale, Arizona, with a listed address at 61 Spectrum Blvd, the company was formerly known as The PAWS Pet Company, Inc., before changing its name in March 2014. Recent leadership changes include the July 2023 resignation of CEO and sole board member Daniel Oswald, replaced by Sean Daly in the same roles across all subsidiaries.

Company News

APIChat

  • defenseworld.net

    Head-To-Head Review: Madrigal Pharmaceuticals (NASDAQ:MDGL) and Praxsyn (OTCMKTS:PXYN)